FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

106781000036104: Duloxetine (DRLA) (duloxetine 30 mg) enteric capsule (trade product unit of use)


Status: current, Defined. Date: 30-Apr 2013. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
523441000036113 Duloxetine (DRLA) 30 mg enteric capsule en Synonym Active Case sensitive Australian Medicines Terminology module
523451000036111 Duloxetine (DRLA) (duloxetine 30 mg) enteric capsule (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Duloxetine (DRLA) 30 mg enteric capsule has Australian BoSS duloxetine true Inferred relationship Some 538505722
Duloxetine (DRLA) 30 mg enteric capsule has unit of use capsule true Inferred relationship Some 538505723
Duloxetine (DRLA) 30 mg enteric capsule has intended active ingredient duloxetine true Inferred relationship Some 538505722
Duloxetine (DRLA) 30 mg enteric capsule Is a trade product unit of use true Inferred relationship Some
Duloxetine (DRLA) 30 mg enteric capsule Is a Duloxetine (DRLA) true Inferred relationship Some
Duloxetine (DRLA) 30 mg enteric capsule Is a duloxetine 30 mg enteric capsule true Inferred relationship Some
Duloxetine (DRLA) 30 mg enteric capsule has manufactured dose form enteric capsule true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Duloxetine (DRLA) 30 mg enteric capsule, 28, blister pack has TPUU True Duloxetine (DRLA) 30 mg enteric capsule Inferred relationship Some 1
Duloxetine (DRLA) 30 mg enteric capsule, 28 has TPUU True Duloxetine (DRLA) 30 mg enteric capsule Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start